Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)

Condition:   Candidiasis, InvasiveInterventions:   Drug: Caspofungin;   Drug: Amphotericin B DeoxycholateSponsor:   Merck Sharp & Dohme Corp.Recruiting - verified May 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials